WATKINS TIM (CMO & Head of Development) sold 54.7% of their position (10.83K shares) of CONTINEUM THERAPEUTICS, INC. on the open market
Open‑market sale worth $173.6K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/1/2026ACC: 0001628280-26-046654
Officer· CMO & Head of Development
Since Mar 2026
-10.83K
Net shares
Net seller
$173.6K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
10.83K acquired · 21.67K disposed
Non-Derivative Transactions2
Class A Common Stock
Direct
Shares
+10.83K
Price / share
$4.50
Trade value
$48.75K
% of position
120.9%
6/30/2026
8.96K→19.79K
Class A Common Stock
Direct
Shares
−10.83K
Price / share
$16.02
Trade value
$173.59K
% of position
54.7%
6/30/2026
19.79K→8.96K
Total
Net shares
+0.00
Net value
-$124.84K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 6/30/2026 | M · Option Exercise | +10.83K | $4.50 | $48.75K | 120.9% | 8.96K | 19.79K |
| Class A Common Stock Direct | 6/30/2026 | S · Sale | −10.83K | $16.02 | $173.59K | 54.7% | 19.79K | 8.96K |
| Total | +0.00 | -$124.84K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Class A Common Stock
10.83K shares
Shares
−10.83K
Strike price
4.50
Held after
238.33K
Exercisable
—
6/30/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Class A Common Stock10.83K shares | 6/30/2026 | M · Option Exercise | −10.83K | 4.50 | — | 238.33K |